SK Biopharmaceuticals Co., Ltd. (326030.KS) KSC
102,000.00
+2800(+2.82%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
102,000.00
+2800(+2.82%)
Currency In KRW
| Market Cap | 9.76T |
| Enterprise Value | 9.5T |
| P/E Ratio | 22.62 |
| PEG Ratio | 0.67 |
| Price/Sales Ratio | 10.15 |
| Price/Book Ratio | 9.64 |
| Enterprise/Revenue | 9.82 |
| Enterprise/EBITDA | 45.08 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.44 |
| Operating Margin | 0.34 |
| Return On Assets | 0.29 |
| Return On Equity | 0.52 |
| Revenue | 706.74B |
| Revenue/Share | 10,329.39 |
| Gross Profit | 651.67B |
| EBITDA | 220.89B |
| Net Income | 266.95B |
| Diluted EPS | 3,408.75 |
| Total Cash | 309.48B |
| Total Cash/Share | 4,045.25 |
| Total Debt | 48.92B |
| Total Debt/Equity | 0.06 |
| Current Ratio | 2.31 |
| Book Value Per Share | 10,800.2 |
| 52-Week Change | 11.18 |
| 52-Week High | 144,100 |
| 52-Week Low | 87,900 |
| Moving Average 50 Days | 99,558 |
| Moving Average 200 Days | 110,915.5 |
| Average Volume | 411,056 |
| Shares Outstanding | 78.31M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |